BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 11888905)

  • 21. Carcinogen-induced phenotypic alterations in mammary epithelial cells accompanying the development of neoplastic transformation.
    Greiner JW; DiPaolo JA; Evans CH
    Cancer Res; 1983 Jan; 43(1):273-8. PubMed ID: 6401165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced in vitro proliferation and in vivo tumorigenic potential of mammary epithelium from BALB/c mice exposed in vivo to gamma-radiation and/or 7,12-dimethylbenz[a]anthracene.
    Adams LM; Ethier SP; Ullrich RL
    Cancer Res; 1987 Aug; 47(16):4425-31. PubMed ID: 3111686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NTP Toxicity Studies of 60-Hz Magnetic Fields Administered by Whole Body Exposure to F344/N Rats, Sprague-Dawley Rats, and B6C3F1 Mice.
    Toxic Rep Ser; 1996 Sep; 58():1-B6. PubMed ID: 11986681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of cell proliferation, micronuclei and hyperdiploidy/polyploidy in the mammary cells of DDT- and DMBA-treated pubertal rats.
    Uppala PT; Roy SK; Tousson A; Barnes S; Uppala GR; Eastmond DA
    Environ Mol Mutagen; 2005 Jul; 46(1):43-52. PubMed ID: 15880734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 60 Hz magnetic field exposure and urinary 6-sulphatoxymelatonin levels in the rat.
    John TM; Liu GY; Brown GM
    Bioelectromagnetics; 1998; 19(3):172-80. PubMed ID: 9554695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acceleration of mammary tumorigenesis by exposure of 7,12-dimethylbenz[a]anthracene-treated female rats in a 50-Hz, 100-microT magnetic field: replication study.
    Mevissen M; Häussler M; Lerchl A; Löscher W
    J Toxicol Environ Health A; 1998 Mar; 53(5):401-18. PubMed ID: 9515942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study on potential effects of "902-MHz GSM-type Wireless Communication Signals" on DMBA-induced mammary tumours in Sprague-Dawley rats.
    Hruby R; Neubauer G; Kuster N; Frauscher M
    Mutat Res; 2008 Jan; 649(1-2):34-44. PubMed ID: 17981079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seasonal influence on 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis in Sprague-Dawley rats under controlled laboratory conditions.
    Löscher W; Mevissen M; Häussler B
    Pharmacol Toxicol; 1997 Dec; 81(6):265-70. PubMed ID: 9444667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of melatonin on mammary carcinogenesis in intact and pinealectomized rats in varying photoperiods.
    Shah PN; Mhatre MC; Kothari LS
    Cancer Res; 1984 Aug; 44(8):3403-7. PubMed ID: 6430548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
    Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM
    Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of 50 Hz magnetic field exposure on the stress marker α-amylase in the rat mammary gland.
    Fedrowitz M; Hass R; Löscher W
    Int J Radiat Biol; 2012 Jul; 88(7):556-64. PubMed ID: 22563858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estradiol and phytoestrogens differently influence the rodent postmenopausal mammary gland.
    Gallo D; Zannoni GF; Martinelli E; Ferlini C; Fabrizi M; Riva A; Morazzoni P; Bombardelli E; Scambia G
    Menopause; 2006; 13(1):72-9. PubMed ID: 16607101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NTP Toxicology and Carcinogenesis Studies of 2,2-Bis(Bromomethyl)-1,3-Propanediol (FR-1138(R)) (CAS No. 3296-90-0) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 May; 452():1-465. PubMed ID: 12594523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opposing effects of prepubertal low- and high-fat n-3 polyunsaturated fatty acid diets on rat mammary tumorigenesis.
    Olivo SE; Hilakivi-Clarke L
    Carcinogenesis; 2005 Sep; 26(9):1563-72. PubMed ID: 15888492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of treatment of rats with indole-3-carbinol on apoptosis in the mammary gland and mammary adenocarcinomas.
    Zhang X; Malejka-Giganti D
    Anticancer Res; 2003; 23(3B):2473-9. PubMed ID: 12894530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo exposure of rats to a weak alternating magnetic field increases ornithine decarboxylase activity in the mammary gland by a similar extent as the carcinogen DMBA.
    Mevissen M; Kietzmann M; Löscher W
    Cancer Lett; 1995 Apr; 90(2):207-14. PubMed ID: 7736457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diethylstilbestrol intervention in carcinogenesis of breast cancer in wistar rats].
    Chen H; Geng CZ; Kuang G; Wang GL; Fan ZL; Wu XD
    Ai Zheng; 2007 Jun; 26(6):596-600. PubMed ID: 17562264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do cocarcinogenic effects of ELF electromagnetic fields require repeated long-term interaction with carcinogens? Characteristics of positive studies using the DMBA breast cancer model in rats.
    Löscher W
    Bioelectromagnetics; 2001 Dec; 22(8):603-14. PubMed ID: 11748679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of mammary epithelial cell differentiation and inhibition of dimethylbenz(A)anthracene-induced mammary tumour by co-administration of a pure antiestrogen ICI 182,780 and testosterone enanthate.
    Chan TW; Mark G; Huynh H
    Int J Oncol; 2001 Aug; 19(2):263-9. PubMed ID: 11445837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.